ArticleBMC surgery2026
Intraoperative complications during gender-affirming laparoscopic hysterectomy in transgender men receiving testosterone: a case series.
Article in BMC surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLaparoscopic hysterectomy is a core component of gender-affirming care for transgender men. However, long-term testosterone therapy can lead to anatomical and tissue changes that increase the complexity of pelvic surgery.
objectiveTo describe the intraoperative complications encountered during gender-affirming laparoscopic hysterectomy in transgender men receiving testosterone therapy and discuss strategies for mitigation.
methodsThis retrospective case series includes four transgender men undergoing total laparoscopic hysterectomy at a tertiary academic center. All patients were nulliparous virgins with ≥ 2.5 years of testosterone therapy. Clinical data, intraoperative events, and management strategies were analyzed.
resultsIntraoperative complications included posterior cul-de-sac perforation (n = 1), cervical avulsion requiring conversion to laparotomy (n = 1), bladder dome injury (n = 1), and deep vaginal lacerations (n = 4). Contributing factors were cervical atrophy, stenosis, and limited vaginal elasticity due to long-term testosterone exposure. Multidisciplinary support was required in two cases (urology and vascular surgery). All patients recovered without long-term sequelae, although one expressed dissatisfaction with abdominal scarring.
conclusionGender-affirming hysterectomy in transgender men presents unique challenges related to testosterone-induced anatomic changes. Preoperative planning, gentle tissue handling, customized instrumentation, and patient counseling are critical to reduce risk and optimize outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.